Literature DB >> 33044377

Incidence of Nongonococcal Urethritis in Men Who Have Sex With Women and Associated Risk Factors.

Emily Rowlinson1, James P Hughes2, Laura C Chambers1, M Sylvan Lowens3, Jennifer L Morgan3, Tashina S Robinson1, Sarah S Romano1, Gina L Leipertz1, Olusegun O Soge, Matthew R Golden, Lisa E Manhart.   

Abstract

BACKGROUND: Incidence and risk factors for nongonococcal urethritis (NGU) remain poorly defined. We conducted a cohort study to estimate the incidence of NGU and identify risk factors in men who have sex with women.
METHODS: We enrolled cisgender male sexually transmitted disease clinic attendees 16 years or older who reported exclusively female partners. At enrollment and 6 monthly follow-up visits, men underwent a clinical examination, provided urethral swab and urine specimens, completed a sexual behavior survey and biweekly diaries, and were tested for Chlamydia trachomatis (CT) and Mycoplasma genitalium (MG) using Aptima assays (Hologic, Inc). Nongonococcal urethritis was defined as ≥5 polymorphonuclear leukocytes per high-power field plus either urethral symptoms or visible discharge. We estimated the incidence of NGU overall, asymptomatic and symptomatic NGU, non-CT/non-MG NGU, and CT/MG-associated NGU using Poisson regression for clustered outcomes. We performed relative risk binomial regression for clustered data to identify characteristics associated with incident NGU.
RESULTS: From August 2014 to July 2018, 307 participants at risk for NGU contributed 109.4 person-years. Median age was 32 years, and 52% were White. At enrollment, 107 men had NGU; of these, 88% were symptomatic, 27% had CT, and 22% had MG. Fifty men had 60 cases of incident NGU (incidence rate, 56 per 100 person-years; 95% confidence interval, 43-74). Unlike prevalent NGU at enrollment, CT/MG-associated incident NGU was rare (incidence rate, 7; 95% confidence interval [CI], 4-15), and most (78%) incident NGU was asymptomatic. Risk factors for incident NGU were ≤ high school education (adjusted rate ratio [ARR], 2.45; 95% CI, 1.19-5.00), history of CT (ARR, 2.15; 95% CI, 1.08-4.27), history of NGU (ARR, 2.67; 95% CI, 1.27-5.62), and NGU at enrollment (ARR, 2.03; 95% CI, 1.04-3.98). Neither condom use nor having a new partner was associated with incident NGU; Black race was only associated with incident symptomatic and non-CT/non-MG NGU.
CONCLUSIONS: Incidence of NGU was high, predominantly non-CT/non-MG and asymptomatic. Future studies should investigate the etiology and clinical significance of asymptomatic NGU.
Copyright © 2020 American Sexually Transmitted Diseases Association. All rights reserved.

Entities:  

Mesh:

Year:  2021        PMID: 33044377      PMCID: PMC8893602          DOI: 10.1097/OLQ.0000000000001314

Source DB:  PubMed          Journal:  Sex Transm Dis        ISSN: 0148-5717            Impact factor:   2.830


  24 in total

Review 1.  Clinical management of foreign bodies of the genitourinary tract.

Authors:  A van Ophoven; J B deKernion
Journal:  J Urol       Date:  2000-08       Impact factor: 7.450

2.  Research electronic data capture (REDCap)--a metadata-driven methodology and workflow process for providing translational research informatics support.

Authors:  Paul A Harris; Robert Taylor; Robert Thielke; Jonathon Payne; Nathaniel Gonzalez; Jose G Conde
Journal:  J Biomed Inform       Date:  2008-09-30       Impact factor: 6.317

3.  How to manage the chronic pelvic pain syndrome in men presenting to sexual health services.

Authors:  Megan Crofts; Kate Mead; Raj Persad; Paddy Horner
Journal:  Sex Transm Infect       Date:  2014-06-06       Impact factor: 3.519

4.  Association of antibodies to Chlamydia trachomatis heat-shock protein 60 kD with chronic nongonococcal urethritis.

Authors:  P J Horner; D Cain; M McClure; B J Thomas; C Gilroy; M Ali; J N Weber; D Taylor-Robinson
Journal:  Clin Infect Dis       Date:  1997-04       Impact factor: 9.079

5.  Long Duration of Asymptomatic Mycoplasma genitalium Infection After Syndromic Treatment for Nongonococcal Urethritis.

Authors:  Sarah S Romano; Jørgen S Jensen; M Sylvan Lowens; Jennifer L Morgan; Laura C Chambers; Tashina S Robinson; Patricia A Totten; Olusegun O Soge; Matthew R Golden; Lisa E Manhart
Journal:  Clin Infect Dis       Date:  2019-06-18       Impact factor: 9.079

6.  Idiopathic urethritis in young men in the United States: prevalence and comparison to infections with known sexually transmitted pathogens.

Authors:  Catherine M Wetmore; Lisa E Manhart; Matthew R Golden
Journal:  J Adolesc Health       Date:  2009-09-03       Impact factor: 5.012

7.  Chemotactic activity of urethral secretions in men with urethritis and the effect of treatment.

Authors:  D A Lomas; D Natin; R A Stockley; M Shahmanesh
Journal:  J Infect Dis       Date:  1993-01       Impact factor: 5.226

8.  2016 European guideline on the management of non-gonococcal urethritis.

Authors:  Patrick J Horner; Karla Blee; Lars Falk; Willem van der Meijden; Harald Moi
Journal:  Int J STD AIDS       Date:  2016-05-04       Impact factor: 1.359

9.  Prevalence of Mycoplasma genitalium Infection, Antimicrobial Resistance Mutations, and Symptom Resolution Following Treatment of Urethritis.

Authors:  Laura H Bachmann; Robert D Kirkcaldy; William M Geisler; Harold C Wiesenfeld; Lisa E Manhart; Stephanie N Taylor; Arlene C Seña; Candice J McNeil; Lori Newman; Noelle Myler; Rachael Fuchs; Katherine E Bowden
Journal:  Clin Infect Dis       Date:  2020-12-17       Impact factor: 9.079

10.  Factors associated with asymptomatic non-chlamydial non-gonococcal urethritis in heterosexual men: findings from a case-control study.

Authors:  J M Saunders; C H Mercer; L J Sutcliffe; J A Cassell; C S Estcourt
Journal:  Int J STD AIDS       Date:  2013-07-19       Impact factor: 1.359

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.